Nov 14, 2025 08:00AM
May 21, 2025 07:10AM
May 12, 2025 07:31AM
May 12, 2025 07:30AM
Apr 30, 2025 07:00AM
Apr 28, 2025 08:28AM
Apr 28, 2025 08:28AM Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers
Apr 16, 2025 07:00AM
Mar 10, 2025 08:57AM
Nov 15, 2024 07:00AM
Aug 16, 2024 08:12AM
Jul 25, 2024 07:35AM
Jul 25, 2024 07:35AM
Jun 27, 2024 07:46AM Purple Biotech (PPBT) Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
Jun 27, 2024 07:45AM
Apr 25, 2024 07:00AM
Feb 27, 2024 07:00AM
Feb 13, 2024 07:04AM
Feb 13, 2024 07:00AM
Feb 1, 2024 07:31AM
Feb 1, 2024 07:30AM Purple Biotech Reaches Recommended Phase 2 Dose for NT219
Dec 20, 2023 08:06AM
Nov 21, 2023 06:50AM
Oct 19, 2023 03:55PM
Oct 3, 2023 07:50AM
Oct 3, 2023 07:50AM
May 16, 2023 04:00PM
Apr 25, 2023 08:00AM Purple Biotech Debuts Scientific Advisory Board
Apr 19, 2023 08:16AM
Apr 19, 2023 08:15AM
Apr 18, 2023 07:00AM
Mar 24, 2023 07:02AM
Mar 24, 2023 07:00AM
Mar 16, 2023 07:00AM
Feb 14, 2023 07:01AM Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial
Feb 8, 2023 07:12AM
Feb 2, 2023 07:07AM
Feb 2, 2023 07:00AM
Jan 3, 2023 07:04AM
Jan 3, 2023 07:00AM
Nov 15, 2022 07:03AM
Nov 15, 2022 07:00AM Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
Nov 8, 2022 07:53AM
Nov 2, 2022 07:38AM
Nov 2, 2022 07:37AM
Aug 4, 2022 07:30AM
Jul 14, 2022 07:30AM
May 27, 2022 07:15AM
May 27, 2022 07:14AM Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022, Demonstrating Encouraging Safety & Efficacy Profile
May 18, 2022 08:18AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All